Back
Nektar Therapeutics Stock Price Chart
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
41
NKTR
Nektar Therapeutics
Last Price:
$57.53
Seasonality Move:
15.47%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is moderately bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.08 | Sell |
| 20-day SMA: | 58.29 | Sell |
| 50-day SMA: | 58.66 | Sell |
| 200-day SMA: | 29.35 | Buy |
| 8-day EMA: | 58.75 | Sell |
| 20-day EMA: | 58.74 | Sell |
| 50-day EMA: | 55.72 | Buy |
| 200-day EMA: | 36.74 | Buy |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 48.9 | Sell |
| Chaikin Money Flow: | 424131 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.16 - 61.94) | Sell |
| Bollinger Bands (100): | (30.14 - 61.44) | Buy |
Nektar Therapeutics Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 57.69 while NKTR 8-day simple moving average is 60.08, which is a Sell signal.
-
The stock price of NKTR is 57.69 while Nektar Therapeutics 20-day SMA is 58.29, which makes it a Sell.
-
Nektar Therapeutics 50-day simple moving average is 58.66 while NKTR share price is 57.69, making it a Sell technically.
-
NKTR stock price is 57.69 and Nektar Therapeutics 200-day simple moving average is 29.35, creating a Buy signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
41
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $57.69. The Score for NKTR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
998.1M
Price in USD:
57.69
Share Volume:
476.1K
Nektar Therapeutics 52-Week Range
52-Week High:
66.92
52-Week Low:
6.48
Sell
41
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 57.69 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 57.69 while NKTR 8-day exponential moving average is 58.75, which is a Sell signal.
-
The stock price of NKTR is 57.69 while Nektar Therapeutics 20-day EMA is 58.74, which makes it a Sell.
-
Nektar Therapeutics 50-day exponential moving average is 55.72 while NKTR share price is 57.69, making it a Buy technically.
-
NKTR stock price is 57.69 and Nektar Therapeutics 200-day simple moving average is 36.74, creating a Buy signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.22 per share, and a decrease next year of $2.08 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is 0.36, suggesting Nektar Therapeutics is a Buy
-
Nektar Therapeutics Relative Strength Index (RSI) is 48.9, which suggest Nektar Therapeutics is oversold
-
The Bollinger Bands (25) for Nektar Therapeutics is (55.16 - 61.94), which suggest Nektar Therapeutics is a Buy
-
The Bollinger Bands (100) for Nektar Therapeutics is (30.14 - 61.44), which suggest Nektar Therapeutics is a Buy
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.